Haemonetics Corp reports results for the quarter ended in March - Earnings Summary

Haemonetics

10/05/2022 12:43

* Haemonetics Corp  HAE.N  reported quarterly adjusted
earnings of
65 cents​​ per share for the quarter ended in March. The mean
expectation of seven analysts for the quarter was for earnings
of 60 cents per share.
    * Revenue rose 17.8% to $265.00 million from a year ago; 
analysts
expected $256.47 million. 
    * Haemonetics Corp's reported EPS for the quarter was 19
cents​.
    * The mean earnings estimate of analysts had fallen by
about 6.6%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Haemonetics Corp shares had fallen by 22.1% this
quarter and
lost 7.1% so far this year.
    * The company reported quarterly net income of $9.74
million.
    * Wall Street's median 12-month price target for Haemonetics
Corp
is $68.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 10 at 11:43 a.m.  ​All
figures in US dollars unless otherwise stated